Tetracyclines and their uses in dermatology

References

• Hoigen R, Keller H, Sunntag R, . Miscellaneous antibiotics. Meyler's side effects of drugs, 12th edn., M NG Dukes, et al. Elsevier, Amsterdam 1992; 637–42
   Google Scholar
• Kapusnik-Uiver J, Sande M A, Chambers H F. Antimicrobial agents. Goodman & Gilman's the pharmacological basis of therapeutics, 9th edn, J G Hardman, L E Limbird, P B. Molinoff, et al. McGraw-Hill, New York 1996; 1124–30
   Google Scholar
• Doxycycline. Martindale. The extra pharmacopoeia, 30th edn., J EF Reynolds, K Parfitt. The Pharmaceutical Press, London 1993; 160–1
   Google Scholar
• Minocycline. Martindale, The extra pharmacopoeia, 30th edn., J EF Reynolds, K Parfitt. The Pharmaceutical Press, London 1993; 182–3
   Google Scholar
• Tetracycline. Martindale. The extra pharmacopoeia, 30th edn., J EF Reynolds, K Parfitt. The Pharmaceutical Press, London 1993; 212–16
   Google Scholar
• Doxycycline. The United States pharmacopeia. The national formulary. United States Pharmacopeial Convention, Rock-ville 1995; 555–9
   Google Scholar
• Minocycline. The United States pharmacopeia. The national formulary. United States Pharmacopeial Convention, Rock-ville 1995; 1029–32
   Google Scholar
• Tetracycline. The United States pharmacopeia. The national formulary. United States Pharmacopeial Convention, Rock-ville 1995; 1508–18
   Google Scholar
• Humbert P, Treffel P, Chapuis J F. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691–7
   PubMed Web of Science ®Google Scholar
• Greenwald R A, Golub L M, Lavietes B, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987; 14: 28–32
   PubMed Web of Science ®Google Scholar
• Thong Y H, Freeante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 1979; 35: 443–6
   PubMed Web of Science ®Google Scholar
• Majeski J A, Wesley Alexander J. Evaluation of tetracycline in the neutrophil chemotactic response. J Lab Clin Med 1977; 90: 259–65
   PubMedGoogle Scholar
• Alexander J W. Antibiotic agents and the immune mechanisms of defenses. Bull N Y Acad Med 1975; 51: 1039–45
   PubMedGoogle Scholar
• Elewski B E, Lamb B AJ, Mitchellam W S, et al. In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 1983; 8: 807–12
   PubMed Web of Science ®Google Scholar
• Freinkel R K, Strauss J S, Yip S Y., et al. Effect of tetracycline on the composition of sebum in acne vulgaris. N Engl J Med 1965; 373: 850–4
   Google Scholar
• Cunliffe W J, Foster R A, Greenwood N D., et al. Tetracyclines and acne vulgaris: a clinical and laboratory investigation. BMJ 1973; 4: 332–5
   PubMedGoogle Scholar
• Harrison P V. A combination of doxycycline and minocycline in the treatment of acne vulgaris. Clin Exp Dermatol 1988; 13: 242–4
   PubMed Web of Science ®Google Scholar
• Gough A, Chapman S, Wagstaff K, et al. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996; 312: 169–72
   PubMed Web of Science ®Google Scholar
• McGrae I D, Sonnex T S, Kennedy C TC, et al. Hyperpigmen-tation associated with oral minocycline. Br J Dermatol 1980; 107: 95–102
   Google Scholar
• Fleming C J, Hunt M J, Salisbury E LC, et al. Minocycline-induced hyperpigmentation in leprosy. Br J Dermatol 1996; 134: 784–7
   PubMedGoogle Scholar
• Fenske N A, Millns J L, Greer K E. Minocycline-induced hyperpigmentation at sites of cutaneous inflammation. JAMA 1980; 244: 1103–6
   PubMedGoogle Scholar
• Caro I. Discoloration of the teeth related to minocycline therapy for acne. J Am Acad Dermatol 1980; 3: 317–18
   PubMedGoogle Scholar
• Sabroe R A, Archer C B, Harlow D, et al. Minocycline-induced discoloration of the sclerae. Br J Dermatol 1996; 135: 314–16
   PubMedGoogle Scholar
• Shelley W B, Heaton C L. Minocycline sensitivity. JAMA 1973; 224: 125–7
   PubMedGoogle Scholar
• Petersen C S, Thomsen K. Pseudoporphyria. Ugeskr Laeger 1992; 154: 1713–15
   PubMedGoogle Scholar
• Monaco F, Agnetti V, Mutani R. Benign intracranial hypertension after minocycline therapy. Eur Neurol 1978; 17: 48–9
   PubMed Web of Science ®Google Scholar
• Goldbert T M, Patterson R, Pruzansky J J. Systemic allergic reactions to ingested antigens. J Allergy 1969; 44: 96–101
   PubMedGoogle Scholar
• Menon M PS, Das A K. Tetracycline asthma: a case report. Clin Allergy 1977; 7: 285
   PubMedGoogle Scholar
• Shigematsu T, Hojo T, Sakurai I, et al. A case of minocycline-induced pneumonitis which was established by a provocation test. J Jpn Soc Intern Med 1988; 77: 1584–5
   PubMedGoogle Scholar
• Kondo A. Epidemiological study of drug-induced pneumonia. Kokyu 1991; 10: 594–603
   Google Scholar
• Domz C A, McNamara D H, Holzapfel H F. Tetracycline provocation in lupus erythematosus. Ann Intern Med 1959; 50: 1217–26
   PubMedGoogle Scholar
• Knowles S R, Shapiro L, Shear N H. Serious adverse reactions induced by minocycline. Arch Dermatol 1996; 132: 934–9
   PubMed Web of Science ®Google Scholar
• Shapiro L E, Knowels S R, Shear N H. Comparative safety of tetracycline, minocycline and doxycycline. Arch Dermatol 1997; 133: 1224–30
   PubMed Web of Science ®Google Scholar
• Wullen F, Kast G, Bruck A. On side-effects of tetracycline administration in myasthenic patients. Dtsch Med Wochenschr 1967; 92: 667–9
   PubMedGoogle Scholar
• Drug interactions. A source book of adverse interactions, their mechanisms, clinical importance and management, 2nd edn, I H Stockley. Blackwell Scientific Publications, Oxford 1991; 146–152, 208, 332, 333, 365, 387, 432, 473, 581, 620.
   Google Scholar
• Schaffner W. The rickettsioses. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2499–506
   Google Scholar
• Eichmann A R. Other venereal diseases. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2764–8
   Google Scholar
• Torok L, Deak J, Scultety S, et al. Role of Chlamydia trachomatis in diseases of the urogenital system. Orv Hetil 1991; 132: 963–6
   PubMedGoogle Scholar
• Rothenberg R B. Lymphogranuloma venereum. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2753–6
   Google Scholar
• Hofmann H. Genital mycoplasma infections - clinical aspect, diagnosis and therapy. Urologe A 1987; 26: 246–51
   PubMedGoogle Scholar
• Rothenberg R B. Granuloma inguinale. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2757–9
   Google Scholar
• Feingold D S, Peacocke M. Gonorrhea. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2760–4
   Google Scholar
• Sanchez M, Luger A FH. Syphilis. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2703–43
   Google Scholar
• Tappeiner G, Wolff K. Tuberculosis and other mycobacterial infections. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 2370–94
   Google Scholar
• Gelber R H, Fukuda K, Byrd S, et al. A clinical trial of minocycline in lepromatous leprosy. BMJ 1992; 304: 91–2
   PubMed Web of Science ®Google Scholar
• Gaspar Z S, Walkden V, Wojnarowska F. Minocycline is a useful adjuvant therapy for pemphigus. 4th Congress of the European Academy of Dermatology and Venereology, Brussels, October, 1995, Abstract 0112
   Google Scholar
• Chaffins M L, Collison D, Fivenson D P. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol 1993; 28: 998–1000
   PubMed Web of Science ®Google Scholar
• Sawai T, Kitazawa K, Danno K, et al. Pemphigus vegetans with oesophageal involvement: successful treatment with minocycline and nicotinamide. Br J Dermatol 1995; 132: 668–70
   PubMed Web of Science ®Google Scholar
• Schaumburg-Lever G, Lever W F. Familial benign pemphigus. Textbook of dermatology, 5th edn., R H Champion, J J Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 642–5
   Google Scholar
• Thornfeldt C R, Menkes A W. Bullous pemphigoid controlled by tetracycline and nicotinamide. A preliminary report. J Am Acad Dermatol 1987; 16: 305–10
   PubMedGoogle Scholar
• Kolbach D N, Remme J J, Bos W H., et al. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 1995; 133: 88–90
   PubMed Web of Science ®Google Scholar
• Peoples D, Fivenson D P. Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol 1992; 26: 498–9
   PubMed Web of Science ®Google Scholar
• Timmer C, Jonkman M F, van der Meer J B. Topical tetracycline in a patient with mucous membrane pemphigoid. 4th Congress of the European Academy of Dermatology and Venereology, Brussels, October, 1995, Abstract C9.
   Google Scholar
• Ronbeck B A, Lind P O, Thrane P S. Desquamative gingivitis: preliminary observations with tetracycline treatment. Oral Surg Oral Med Oral Pathol 1990; 69: 694–7
   PubMedGoogle Scholar
• Reynolds N J, Peachey R DG. Response of atypical bullous pyoderma gangrenosum to oral minocycline hydrochloride and topical steroids. Acta Derm Venereol 1990; 70: 538–9
   PubMed Web of Science ®Google Scholar
• Lynch W B, Borgderfeld W F. Pyoderma gangrenosum responsive to minocycline hydrochloride. Cutis 1978; 21: 535–7
   PubMedGoogle Scholar
• Berth-Jones J, Tan S V, Graham-Brown R AC, Pembroke A C. The successful use of minocycline in pyoderma gangrenosum - a report of seven cases and review of the literature. J Dermatol Treat 1989; 1: 23–5
   Google Scholar
• Amichai B, Lazarov A, Halevy S. Sweet's syndrome and chlamydial infection. Australas J Dermatol 1993; 34: 31–3
   PubMedGoogle Scholar
• Recurrent aphthous stomatitis. Andrew's diseases of the skin, 8th edn., H L Arnold, R B Odom, W D James. WB Saunders, Philadelphia 1990; 938–9
   Google Scholar
• Shelley W B, Griffith R F. Pityriasis lichenoides et varioliformis acuta. A report of a case controlled by high dosage of tetracycline. Arch Dermatol 1969; 100: 596–7
   PubMedGoogle Scholar
• Piamphongsant T. Tetracycline for the treatment of pityriasis lichenoides. Br J Dermatol 1974; 91: 319–22
   PubMed Web of Science ®Google Scholar
• Humbert P, Favire B, Gibey R, Agache P. Use of anti-collagenase properties of doxycycline in the treatment of alpha-1-antitrypsin deficiency panniculitis. Acta Derm Venereol 1991; 71: 189–94
   PubMedGoogle Scholar
• Czamocki N, Tappeiner G, Wolff K. Lupus erythematosus panniculitis. Wien Klin Wochenschr 1979; 91: 830–4
   PubMedGoogle Scholar
• Chan H L. Panniculitis (Rothmann-Makai) with good response to tetracycline. Br J Dermatol 1975; 92: 351–4
   PubMedGoogle Scholar
• Thomsen K, Osterby P. Pustulosis palmaris et plantaris. Br J Dermatol 1973; 89: 293–6
   PubMed Web of Science ®Google Scholar
• Aso M, Miyamoto T, Morimura T, et al. Prurigo pigmentosa successfully treated with minocycline. Br J Dermatol 1989; 120: 705–8
   PubMedGoogle Scholar
• Schepis C, Siragusa M, Palazzo R, et al. Prurigo pigmentosa treated with minocycline. Br J Dermatol 1996; 135: 158–9
   PubMedGoogle Scholar
• Humbert P, Renaud A, Laurent R, et al. Tetracyclines for dystrophic epidermolysis bullosa. Lancet 1989; 1: 277
   Google Scholar
• White J E. Minocycline for dystrophic epidermolysis bullosa. Lancet 1989; 1: 966
   PubMed Web of Science ®Google Scholar
• Takamori K, Natio K, Taneda A, et al. Increased neutral and collagenase activity in recessive dystrophic epidermolysis bullosa. Br J Dermatol 1983; 108: 687–94
   PubMedGoogle Scholar
• McDonagh A GJ, Gawkrodger D J, Walker A E. White sponge nevus successfully treated with topical tetracycline. Clin Exp Dermatol 1990; 15: 152–3
   PubMed Web of Science ®Google Scholar
• Thomsen K. Mycosis fungoides responding to tetracycline. Br J Dermatol 1981; 105: 483–4
   PubMedGoogle Scholar
• Shelley W B. Demethylchlortetracycline and griseofulvine as a specific treatment for mycosis fungoides. Br J Dermatol 1981; 104: 477–80
   PubMedGoogle Scholar
• Angeli-Besson C, Koeppel M C, Jacquet P, et al. Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines. Int J Dermatol 1995; 34: 567–9
   PubMedGoogle Scholar
• Montemarano A D, Hengge M, Sau P, et al. Confluent and reticulated papillomatosis: response to minocycline. J Am Acad Dermatol 1996; 34: 253–6
   PubMedGoogle Scholar
• Halpern S M, Memon A A, Rhodes L E, Friedmann P S. Topical and systemic tetracyclines inhibit nickel-induced contact hypersensitivity. The 78th Annual Meeting of the British Association of Dermatologists, Brighton, July, 1998; 28, (abstract).
   Google Scholar
• Shelley W B. Essential progressive telangiectasia: successful treatment with tetracycline. JAMA 1971; 216: 1343–44
   PubMedGoogle Scholar
• Wallach H W. Intrapleural tetracycline for malignant pleural effusions. Chest 1975; 68: 510–12
   PubMedGoogle Scholar
• Shepherd F A, Morgan C, Evans W K., et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987; 60: 1161–6
   PubMedGoogle Scholar
• Shaw D WW, Bertino R E, Mulholland M W., et al. Use of tetracycline for sclerosis of a biliary-cutaneous fistula. AJR Am J Roentgenol 1989; 153: 65–6
   PubMedGoogle Scholar
• Ding X. Sclerotherapy with tetracycline for hydrocele of the tunica vaginalis testis. Br J Urol 1989; 4: 322
   Google Scholar
• Treece G L, Georgitis W J, Hofeldt F D. Resolution of recurrent thyroid cysts with tetracycline instillation. Arch Intern Med 1983; 143: 2285–7
   PubMedGoogle Scholar
• Tanigaki T, Kanada R. Two cases of eosinophilic pustular folliculitis with effective minocycline therapy. Rinsho Derm 1984; 26: 1129–33
   Google Scholar
• Muto M, Nishimura M, Koga T. Follicular mucinosis responding well to oral minocycline and indomethacine administration. Nishinihon J Dermatol 1988; 50: 428–431
   Google Scholar
• Acne. Andrew's diseases of the skin, 8th edn., H L Arnold, R B Odom, W D James. WB Saunders, Philadelphia 1990; 250–62
   Google Scholar
• Frucht-Pery J, Chayet A S, Feldman S T., et al. The effect of doxycycline on ocular rosacea. Am J Ophthalmol 1989; 107: 434–5
   PubMed Web of Science ®Google Scholar
• Amichai B, Grunwald M H, Avinoach I, et al. Granulomatous rosacea associated with Demodex folliculorum. Int J Dermatol 1992; 31: 718–19
   PubMedGoogle Scholar
• Perioral dermatitis. Andrew's diseases of the skin, 8th edn., H L Arnold, R B Odom, W D James. WB Saunders, Philadelphia 1990; 267
   Google Scholar
• Urabe H, Koda H. Perioral dermatitis and rosacea-like dermatitis. Clinical features and treatment. Dermatologica 1976; 152(Suppl 1)155–60
   PubMedGoogle Scholar
• Liegner K B. Minocycline in Lyme disease. J Am Acad Dermatol 1992; 26: 263–4
   PubMedGoogle Scholar
• Abele D C, Anders K H. The many faces and phases of borreliosis I. Lyme disease. J Am Acad Dermatol 1990; 23: 167–86
   PubMedGoogle Scholar
• Abele D C, Anders K H. The many faces and phases of borreliosis II. Lyme disease. J Am Acad Dermatol 1990; 23: 401–10
   PubMedGoogle Scholar
• Amichai B, Grunwald M H, Halevy S. Borrelia burgdorferi and skin diseases. Harefuah 1994; 126: 214–18
   PubMedGoogle Scholar
• Kleinhans D. Oral tetracyclines: the therapy of choice in chronic erythema migrans. Z Hautkr 1985; 60: 327–8
   PubMedGoogle Scholar